Sir,
The mini review on aspirin and cancer questions whether the medicine has been overlooked as an adjuvant therapy (Langley et al, 2011). Although the focus of the mini review was on adult cancer, perhaps aspirin might also be helpful in childhood cancer. There is evidence that childhood cancer survivors have increased risks of both cancer and cardiovascular disease when compared with the general population (Mulrooney et al, 2009; Reulen et al, 2011). Given the evidence supporting aspirin reducing the risk of both cancer and cardiovascular disease (Rose et al, 2011), potentially the medicine could be helpful in the proactive health care of survivors. Such potential does need to take into account the undesirable effects of aspirin.
Aspirin is not recommended for children, hence compared with adults, it is more difficult to make a case for aspirin as adjuvant therapy in childhood cancer. This does not mean it should not be considered at all, and perhaps the ethical aspects of low doses of aspirin as adjuvant therapy in childhood cancer need further exploration. In the meantime, perhaps a readily available alternative might be also considered. Salicylate is the putative active component of aspirin against cancer cells through several mechanisms and it might be ingested through diet. Perhaps a diet rich in salicylate, such as fruits and vegetables, could be considered as adjuvant therapy. This might also help promote the general health and wellbeing of children with cancer.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Langley RE, Burdett S, Tierney JF, Cafferty F, Parmar MKB, Venning G (2011) Aspirin and cancer : has aspirin been overlooked as an adjuvant therapy? Br J Cancer; e-pub ahead of print 16 August 2011; doi:10.1038/bjc.2011.289
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklae CA, Robison LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339: b4606
Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM, British Childhood Cancer Survivor Study Steering Group (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305 (22): 2311–2319
Rose PW, Watson EK, Jenkins LS (2011) Aspirin for prevention of cancer and cardiovascular disease. Br J Gen Pract 61 (587): 412–415
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Morgan, G. Aspirin as adjuvant therapy in childhood cancer?. Br J Cancer 106, 240 (2012). https://doi.org/10.1038/bjc.2011.467
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2011.467